Vitamin D status and bone density in steroid-treated children with glomerulopathies: Effect of cholecalciferol and calcium supplementation

Advances in Medical Sciences

Volumn 57, Issue 1, 2012, Pages 88-93

  Zaniew, M ^a   Jarmolinski T ^a  

^a Department of Pediatrics Nephrology and Toxicology   (Poland)

Author keywords

25 hydroxyvitamin D; bone mineral density; children; glucocorticosteroids; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; AZATHIOPRINE; CALCIUM; COLECALCIFEROL; CYCLOSPORIN A; GLUCOCORTICOID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARATHYROID HORMONE; TACROLIMUS; VITAMIN D;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; CALCIUM EXCRETION; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOCAL GLOMERULONEPHRITIS; FOCAL GLOMERULOSCLEROSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; NUTRITIONAL STATUS; PRESCHOOL CHILD; PROPHYLAXIS; RETROSPECTIVE STUDY; SCHOOL CHILD; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84865156534     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-012-0016-8     Document Type: Article

References (24)

1. Leonard MB. Glucocorticoid-induced osteoporosis in children: impact of the underlying disease. Pediatrics. 2007 Mar;119 Suppl 2:S166-74
2. Gordon CL, Halton JM, Atkinson SA, Webber CE. The contributions of growth and puberty to peak bone mass. Growth Dev Aging. 1991 Winter;55(4):257-62
3. Wetzsteon RJ, Shults J, Zemel BS, Gupta PU, Burnham JM, Herskovitz RM, Howard KM, Leonard MB. Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome. J Bone Miner Res. 2009 Mar;24(3):503-13
4. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S-88S
5. Boot AM, Krenning EP, de Muinck Keizer-Schrama SM. The relation between 25-hydroxyvitamin D with peak bone mineral density and body composition in healthy young adults. J Pediatr Endocrinol Metab. 2011;24(5-6):355-60
6. Hollis BW. Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int. 1996 Jan;58(1):4-5
7. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med. 2004 Jun;158(6):531-7
8. Guillemant J, Taupin P, Le HT, Taright N, Allemandou A, Péres G, Guillemant S. Vitamin D status during puberty in French healthy male adolescents. Osteoporos Int. 1999;10(3):222-5
9. Grymonprez A, Proesmans W, Van Dyck M, Jans I, Goos G, Bouillon R. Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol. 1995 Jun;9(3):278-81
10. Weng FL, Shults J, Herskovitz RM, Zemel BS, Leonard MB. Vitamin D insufficiency in steroid-sensitive nephrotic syndrome in remission. Pediatr Nephrol. 2005 Jan;20(1):56-63
11. Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements. Nephrol Dial Transplant. 2005 Aug;20(8):1598-603
12. Bak M, Serdaroglu E, Guclu R. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Pediatr Nephrol. 2006 Mar;21(3):350-4
13. Hodson EM, Alexander SI, Graf N. Steroid-sensitive nephrotic syndrome. In: Geary DF, Schaefer F, editors. Comprehensive Pediatric Nephrology. Philadelphia: Mosby Elsevier; 2008. p. 239-256
14. Shroff R, Knott C, Rees L. The virtues of vitamin D-but how much is too much? Pediatr Nephrol. 2010Sep;25(9):1607-20
15. Bachrach LK, Sills IN; Section on Endocrinology.Clinical report-bone densitometry in children and adolescents.Pediatrics. 2011 Jan;127(1):189-94
16. Kułaga Z, Litwin M, Tkaczyk M, Palczewska I, Zaja̧czkowska M, Zwolińska D, Krynicki T, Wasilewska A,Moczulska A, Morawiec-Knysak A, Barwicka K, Grajda A, Gurzkowska B, Napieralska E, Pan H. Polish 2010 growthreferences for school-aged children and adolescents. Eur J Pediatr. 2011 May;170(5):599-609
17. Vieth R. Critique of the considerations for establishingthe tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr. 2006 Apr;136(4):1117-22.
18. Gulati S, Godbole M, Singh U, Gulati K, SrivastavaA. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease? Am J Kidney Dis. 2003Jun;41(6):1163-9
19. Misra M, Pacaud D, Petryk A, Collert-Solberg PF, Kappy M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics.2008 Aug;122(2):398-417
20. Uhlig K, Berns JS, Kestenbaum B, Kumar R,Leonard MB, Martin KJ, Sprague SM, Goldfarb S. KDOQI UScommentary on the 2009 KDIGO Clinical Practice Guidelinefor the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis. 2010May;55(5):773-99
21. Adams JS, Kantorovich V, Wu C, Javanbakht M, Hollis BW. Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab. 1999 Aug;84(8):2729-30
22. Winzenberg T, Powell S, Shaw KA, Jones G. Effects of vitamin D supplementation on bone density in healthychildren: systematic review and meta-analysis. BMJ. 2011 Jan25;342:c7254
23. Ringe JD, Dorst A, Faber H, Schacht E, Rahlfs VW. Superiority of alfacalcidol over plain vitamin D in thetreatment of glucocorticoid-induced osteoporosis. RheumatolInt. 2004 Mar;24(2):63-70
24. Mehls O. Is it correct to supplement patients withnephrotic syndrome with vitamin D and calcium? PediatrNephrol. 1990 Sep;4(5):519